RT Journal Article
SR Electronic
T1 Reduced survival in COPD patients who received long-term oxygen therapy without meeting prescription criteria: a preliminary study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19000760
DO 10.1101/19000760
A1 François Alexandre
A1 Alain Varray
A1 Yannick Stéphan
A1 Maurice Hayot
A1 Nelly Héraud
YR 2019
UL http://medrxiv.org/content/early/2019/07/08/19000760.abstract
AB Background Randomized clinical trials have provided clear evidence that long-term oxygen therapy (LTOT) increases life expectancy in severely hypoxemic COPD patients. However, in real-life settings, in global COPD cohorts, a paradoxical 2-3-fold increased risk of death has been reported in patients under LTOT. This discrepancy could be explained by a subgroup of patients under LTOT who do not meet the current guidelines and for whom LTOT would be associated with poor prognosis. This retrospective study of a global COPD cohort therefore sought to: (1) determine if a subgroup of patients under LTOT without severe hypoxemia could be distinguished, and (2) compare the mortality risk according to hypoxemia severity and LTOT prescription.Method The sample was taken from a database (NCT02055885) on 191 stable COPD patients (age: 65.1±9.8 years, 85 women) admitted for a pulmonary rehabilitation program between 2009 and 2012 and followed until 1 January 2018. Uni- and multivariate Cox proportional hazard ratio (HR) models were used to examine the associations between clinical characteristics (age, sex, blood gases, etc.), LTOT according to PaO2 level, and mortality.Results Forty patients (21%) were under LTOT at PR entry despite not meeting the O2 prescription criteria. Patients under LTOT had a nearly 2-fold higher mortality risk adjusted by covariates (HRmultivariate=1.83; p=0.009). Furthermore, the higher mortality risk under LTOT was specific to the patients under LTOT without severe hypoxemia (HRmultivariate=2.39; p=0.04).Conclusion The association between LTOT and mortality might be attributed to a subgroup under LTOT despite not/no longer meeting the LTOT criteria. Further studies are needed to identify the physiological basis of this phenomenon.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.NAI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.NAThe data are fully available on request to comitederecherche@5-sante.fr